Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer

Oncogene

Volumn 22, Issue 5, 2003, Pages 761-768

  Tsai, Miaw Sheue ^a   Shamon Taylor, Lisa A ^a,d   Mehmi, Inderjit ^b   Tang, Careen K ^c   Lupu, Ruth ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d ALZA CORPORATION   (United States)

Author keywords

Antisense; Breast cancer; HRG; Metastasis; Tumorigenicity

Indexed keywords

COMPLEMENTARY DNA; GELATINASE B; NEU DIFFERENTIATION FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST METASTASIS; CANCER CELL CULTURE; CANCER GENETICS; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; EMBRYO; ENZYME ACTIVITY; GENE ACTIVATION; GENE OVEREXPRESSION; IN VITRO STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; ONCOGENE NEU; PHENOTYPE; PRIORITY JOURNAL; TUMOR PROMOTION; TUMOR VOLUME;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, ERBB-2; HUMANS; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM METASTASIS; NEUREGULIN-1; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0037421965     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206130     Document Type: Article

References (33)

1. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP and Kraus MH. (1995). Oncogene, 10, 1813-1821.
2. Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C and Lupu R. In Press: Molecular Cancer Research (2003).
3. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M and Lupu R. (1992). Cell Growth Differ., 3, 401-411.
4. Cardillo M, Tang CK and Lupu R. Heregulin induces a metastatic phenotype to breast cancer cells in vivo. American Association for Cancer Research. March 1995, Toronto, Canada.
5. Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS and Yarden Y. (1996). J. Biol. Chem., 271, 7620-7629.
6. Curran S and Murray GI. (1999). J. Pathol., 189, 300-308.
7. Grunt TW, Saceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H and Dittrich C. (1995). Int. J. Cancer, 63, 560-567.
8. Guerra-Vladusic FK, Scott G, Weaver V, Vladusic EA, Tsai MS, Benz CC and Lupu R. (1999). Int. J. Oncol., 15, 883-892.
9. Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SC and Lupu R. (2000). Int. J. Oncol. 17, 629-641.
10. Himelstein BP, Lee EJ, Sato H, Seiki M and Muschel RJ. (1997). Oncogene, 14, 1995-1998.
11. Hua J and Muschel RJ. (1996). Cancer Res., 56, 5279-5284.
12. Lee KS, Rha SY, Kim SJ, Kim JH, Roh JK, Kim BS and Chung HC. (1996). Clin. Exp. Metastasis, 14, 512-519.
13. Lim SJ, Lopez-Berestein G, Hung MC, Lupu R and Tari AM. (2000). Oncogene, 19, 6271-6276.
14. Liu W, Guerra-Vladusic FK, Kurakata S, Lupu R and Kohwi-Shigematsu T. (1999). Cancer Res., 59, 5695-5703.
15. Lupu R, Colomer R, Zugmaier G, Sarup J, Shepard M, Slamon D and Lippman ME. (1990). Science, 249, 1552-1555.
16. Lupu R, Cardillo M, Harris L, Hijazi M and Rosenberg K. (1995). Semin. Cancer Biol., 6, 135-145.
17. Lupu R, Colomer R, Kannan B and Lippman ME. (1992a). Proc. Natl. Acad Sci. USA, 89, 2287-2291.
18. Lupu R, Wellstein A, Sheridan J, Ennis BW, Zugmaier G, Katz D, Lippman ME and Dickson RB. (1992b). Biochemistry, 31, 7330-7340.
19. Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippman ME and King CR. (1990). J. Clin. Oncol., 8, 103-112.
20. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP and Aaronson SA. (1991). Oncogene, 6, 1189-1194.
21. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. (1993). Nature, 366, 473-475.
22. Reese DM and Slamon DJ. (1997). Stem Cells, 15, 1-8.
23. Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupu R. (1996). Oncogene, 12, 1679-1687.
24. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
25. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL and Carraway III KL. (1994). J. Biol. Chem., 269, 14661-14665.
26. Sommers CL, Byers SW, Thompson EW, Torri JA and Gelmann EP. (1994). Breast Cancer Res. Treat., 31, 325-335.
27. Stern DF. (2000). Breast Cancer Res., 2, 176-183.
28. Tang CK, Perez C, Grunt T, Waibel C, Cho C and Lupu R. (1996). Cancer Res., 56, 3350-3358.
29. Tripathy D and Benz CC. (1992). Cancer Treat. Res., 63, 15-60.
30. Tsai MS, Hornby AE, Lakins J and Lupu R. (2000). Cancer Res., 60, 5603-5607.
31. Tsai MS, Bogart DF, Costanede J, Li P and Lupu R. (2002). Oncogene, 21, 8178-8185.
32. Tsang KJ and Crowe DL. (2001). Int. J. Oncol., 18, 369-374.
33. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P and Yu D. (2001). Oncogene, 56, 8066-8074.